Genomic features of complete responders (CR) versus fast progressors (PD) in patients with BRAFV600-mutated metastatic melanoma treated with cobimetinib + vemurafenib or vemurafenib alone Meeting Abstract


Authors: Yan, Y.; Robert, C.; Larkin, J.; Ascierto, P. A.; Dreno, B.; Maio, M.; Garbe, C.; Chapman, P. B.; Sosman, J. A.; Wongchenko, M. J.; Hsu, J. J.; Chang, I.; Caro, I.; Rooney, I.; McArthur, G.; Ribas, A.
Abstract Title: Genomic features of complete responders (CR) versus fast progressors (PD) in patients with BRAFV600-mutated metastatic melanoma treated with cobimetinib + vemurafenib or vemurafenib alone
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: vi379
Language: English
ACCESSION: WOS:000393913000201
DOI: 10.1093/annonc/mdw379.03
PROVIDER: wos
Notes: Meeting Abstract: 1111O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman